Vilacto Bio Inc.
company.status.inactiveCIK 1576724fmd_007304VN6ZW4CAXT8NQ5D4XE8BManufacturing · Perfumes, Cosmetics & Other Toilet PreparationsTemplate: Standard
Coverage: Apr 01, 2012 to Jun 30, 2019, 26 periods
Latest annual · FY2019
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (1)
Latest quarter · Q1 FY2020
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2016 to FY2019
- n/m
- Revenue, 5 yearsFY2014 to FY2019
- n/m
Vilacto Bio Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Revenue | $4,894 | $1,429 | +242.5% | 10-K 2019-07-10 · proof |
| Gross profit | $851 | $846 | +0.6% | 10-K 2019-07-10 · proof |
| Operating income | -$970,039 | -$381,545 | 10-K 2019-07-10 · proof | |
| Cash from operating activities | -$601,153 | -$338,008 | 10-K 2019-07-10 · proof | |
| Total assets | $537,668 | $309,770 | +73.6% | 10-K 2019-07-10 · proof |
| Total liabilities | $4 million | $1.2 million | +217.9% | 10-K 2019-07-10 · proof |
| Cash and cash equivalents | $257,218 | $148,767 | +72.9% | 10-K 2019-07-10 · proof |
- What was Vilacto Bio Inc.'s revenue in fiscal 2019?
- Vilacto Bio Inc. reported revenue of $4,894 for fiscal 2019 (the year ended Mar 31, 2019), against $1,429 the year before (+242.5%). Source: the 10-K filed with the SEC on Jul 10, 2019. SEC
- What was Vilacto Bio Inc.'s gross profit in fiscal 2019?
- Vilacto Bio Inc. reported gross profit of $851 for fiscal 2019 (the year ended Mar 31, 2019), against $846 the year before (+0.6%). Source: the 10-K filed with the SEC on Jul 10, 2019. SEC
- What was Vilacto Bio Inc.'s operating income in fiscal 2019?
- Vilacto Bio Inc. reported operating income of -$970,039 for fiscal 2019 (the year ended Mar 31, 2019), against -$381,545 the year before. Source: the 10-K filed with the SEC on Jul 10, 2019. SEC
- What was Vilacto Bio Inc.'s cash from operating activities in fiscal 2019?
- Vilacto Bio Inc. reported cash from operating activities of -$601,153 for fiscal 2019 (the year ended Mar 31, 2019), against -$338,008 the year before. Source: the 10-K filed with the SEC on Jul 10, 2019. SEC
- What are Vilacto Bio Inc.'s total assets?
- As of Mar 31, 2019, Vilacto Bio Inc. reported total assets of $537,668, against $309,770 a year earlier (+73.6%). Source: the 10-K filed with the SEC on Jul 10, 2019. SEC
- What are Vilacto Bio Inc.'s total liabilities?
- As of Mar 31, 2019, Vilacto Bio Inc. reported total liabilities of $4 million, against $1.2 million a year earlier (+217.9%). Source: the 10-K filed with the SEC on Jul 10, 2019. SEC
- What are Vilacto Bio Inc.'s cash and cash equivalents?
- As of Mar 31, 2019, Vilacto Bio Inc. reported cash and cash equivalents of $257,218, against $148,767 a year earlier (+72.9%). Source: the 10-K filed with the SEC on Jul 10, 2019. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1576724&period_type=annual&limit=5"Information only, not investment advice.